Vitamin D: Effects on childhood health and disease

Nature Reviews Endocrinology

Volumn 9, Issue 3, 2013, Pages 162-170

  Abrams, Steven A ^a   Coss Bu, Jorge A ^a   Tiosano, Dov ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; VITAMIN D;

ACUTE LYMPHOBLASTIC LEUKEMIA; ASTHMA; CHILD HEALTH; CHILDHOOD DISEASE; CYSTIC FIBROSIS; DRUG MECHANISM; DRUG MEGADOSE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPOCALCEMIA; HYPOPHOSPHATEMIC RICKETS; INFECTION PREVENTION; INSULIN DEPENDENT DIABETES MELLITUS; MATERNAL HYPERTENSION; MOTHER FETUS RELATIONSHIP; MULTIPLE SCLEROSIS; NUTRITIONAL REQUIREMENT; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SEASONAL INFLUENZA; SECONDARY HYPERPARATHYROIDISM; TUBERCULOSIS; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ACUTE DISEASE; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH STATUS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; HYPOCALCEMIA; HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; INFANT; INFANT, NEWBORN; INFECTION; MATERNAL-FETAL EXCHANGE; MULTIPLE SCLEROSIS; NUTRITION POLICY; NUTRITIONAL REQUIREMENTS; PREGNANCY; PREMATURE BIRTH; VITAMIN D;

EID: 84875519771     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2012.259     Document Type: Review

References (93)

1. IOM (Institute of Medicine) Dietary Reference Intakes for Calcium and Vitamin D (The National Academies Press, Washington, DC, 2011).
2. Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911-1930 (2011).
3. Christakos, S., Dhawan, P., Porta, A., Mady, L. J. & Seth, T. Vitamin D and intestinal calcium absorption. Mol. Cell. Endocrinol. 347, 25-29, (2011).
4. Teaema, F. H. & Al Ansari, K. Nineteen cases of symptomatic neonatal hypocalcemia secondary to vitamin D deficiency: A 2-year study. J. Trop. Pediatr. 56, 108-110 (2010).
5. Wei, S. Q. et al. Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG 119, 832-839 (2012).
6. Bodnar, L. M. et al. Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab. 92, 3517-3522 (2007).
7. Wagner, C. L. et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol. 208, 137.e1-137.e13 (2013).
8. Hollis, B. W., Johnson, D., Hulsey, T. C., Ebeling, M. & Wagner, C. L. Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. J. Bone Miner. Res. 26, 2341-2357 (2011).
9. Abrams, S. A. Vitamin D supplementation during pregnancy. J. Bone. Miner. Res. 26, 2338-2340 (2011).
10. WHO. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia (WHO, Geneva, 2011).
11. Morales, E. et al. Circulating 25-hydroxyvitamin D3 in pregnancy and infant neuropsychological development. Pediatrics 130, e913-e920 (2012).
12. Hewison, M. An update on vitamin D and human immunity. Clin. Endocrinol. 76, 315-325 (2012).
13. Griffin, M. D. et al. Dendritic cell modulation by 1?, 25-dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl Acad. Sci. USA 98, 6800-6805 (2001).
14. Karvonen, M. et al. Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia. Diabetes Care 21, 1101-1109 (1998).
15. Miettinen, M. E. et al. Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia 55, 1291-1294 (2012).
16. Marjamäki, L. et al. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 53, 1599-1607 (2010).
17. Fronczak, C. M. et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 26, 3237-3242 (2003).
18. Brekke, H. K. & Ludvigsson, J. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr. Diabetes 8, 11-14 (2007).
19. [No authors listed] Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB \ Substudy 2 Study Group. Diabetologia 42, 51-54 (1999).
20. Hyppönen, E., Läära, E., Reunanen, A., Järvelin, M. R. & Virtanen, S. M. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358, 1500-1503 (2001).
21. Simpson, M. et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: The Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 54, 2779-2788 (2011).
22. Gale, C. R. & Martyn, C. N. Migrant studies in multiple sclerosis. Prog. Neurobiol. 47, 425-448 (1995).
23. Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S. & Ascherio, A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296, 2832-2838 (2006).
24. Mirzaei, F. et al. Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann. Neurol. 70, 30-40 (2011).
25. Gale, C. R., Martyn, C. N., Kellingray, S., Eastell, R. & Cooper, C. Intrauterine programming of adult body composition. J. Clin. Endocrinol. Metab. 86, 267-272 (2001).
26. Hartikainen, H., Maleta, K., Kulmala, T. & Ashorn, P. Seasonality of gestational weight gain and foetal growth in rural Malawi. East Afr. Med. J. 82, 294-299 (2005).
27. McGrath, J. J., Saha, S., Lieberman, D. E. & Buka, S. Season of birth is associated with anthropometric and neurocognitive outcomes during infancy and childhood in a general population birth cohort. Schizophr. Res. 81, 91-100 (2006).
28. Weber, G. W., Prossinger, H. & Seidler, H. Height depends on month of birth. Nature 391, 754-755 (1998).
29. Morley, R., Carlin, J. B., Pasco, J. A. & Wark, J. D. Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J. Clin. Endocrinol. Metab. 91, 906-912 (2006).
30. Young, B. E. et al. Maternal vitamin D status and calcium intake interact to affect fetal skeletal growth in utero in pregnant adolescents. Am. J. Clin. Nutr. 95, 1103-1112 (2012).
31. Sayers, A. & Tobias, J. H. Estimated maternal ultraviolet B exposure levels in pregnancy influence skeletal development of the child. J. Clin. Endocrinol. Metab. 94, 765-771 (2009).
32. Javaid, M. K. et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: A longitudinal study. Lancet 367, 36-43 (2006).
33. Walker, V. P. et al. Cord blood vitamin D status impacts innate immune responses. J. Clin. Endocrinol. Metab. 96, 1835-1843 (2011).
34. Tiosano, D., Weisman, Y. & Hochberg, Z. The role of the vitamin D receptor in regulating vitamin D metabolism: A study of vitamin D-dependent rickets, type II. J. Clin. Endocrinol. Metab. 86, 1908-1912 (2001).
35. Hochberg, Z., Tiosano, D. & Even, L. Calcium therapy for calcitriol-resistant rickets. J. Pediatr. 121, 803-808 (1992).
36. Tiosano, D. et al. Calcium absorption, kinetics, bone density, and bone structure in patients with hereditary vitamin D-resistant rickets. J. Clin. Endocrinol. Metab. 96, 3701-3709 (2011).
37. Hochberg, Z. et al. Does 1,25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands? J. Clin. Endocrinol. Metab. 60, 57-61 (1985).
38. Manolagas, S. C., Yu, X. P., Girasole, G. & Bellido, T. Vitamin D and the hematolymphopoietic tissue: A 1994 update. Semin. Nephrol. 14, 129-143 (1994).
39. Etzioni, A. et al. Defective leukocyte fungicidal activity in end-organ resistance to 1,25-dihydroxyvitamin D. Pediatr. Res. 25, 276-279 (1989).
40. Nguyen, M. et al. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): Dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 21, 886-894 (2006).
41. Taylor, C. E. & Camargo, C. A. Jr. Impact of micronutrients on respiratory infections. Nutr. Rev. 69, 259-269 (2011).
42. Beard, J. A., Bearden, A. & Striker, R. Vitamin D and the anti-viral state. J. Clin. Virol. 50, 194-200 (2011).
43. Bruce, D., Ooi, J. H., Yu, S. & Cantorna, M. T. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp. Biol. Med. (Maywood) 235, 921-927 (2010).
44. Urashima, M. et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 91, 1255-1260 (2010).
45. Camargo, C. A. Jr et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 130, e561-e567 (2012).
46. Crowle, A J., Ross, E. J. & May, M. H. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 55, 2945-2950 (1987).
47. Sonawane, A. et al. Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Cell. Microbiol. 13, 1601-1617 (2011).
48. Gibney, K. B. et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin. Infect. Dis. 46, 443-446 (2008).
49. Nnoaham, K. E. & Clarke, A. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. Int. J. Epidemiol. 37, 113-119 (2008).
50. Sasidharan, P. K., Rajeev, E. & Vijayakumari, V. Tuberculosis and vitamin D deficiency. J. Assoc. Physicians India 50, 554-558 (2002).
51. Ustianowski, A., Shaffer, R., Collin, S., Wilkinson, R. J. & Davidson, R. N. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J. Infect. 50, 432-437 (2005).
52. Wejse, C. et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am. J. Clin. Nutr. 86, 1376-1383 (2007).
53. Martineau, A. R. et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur. Respir. J. 35, 1106-1112 (2010).
54. Williams, B., Williams, A. J. & Anderson, S. T. Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr. Infect. Dis. J. 27, 941-942 (2008).
55. Gray, K. et al. Vitamin D and tuberculosis status in refugee children. Pediatr. Infect. Dis. J. 31, 521-523 (2012).
56. Martineau, A. R. et al. A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med. 176, 208-213 (2007).
57. Sinclair, D., Abba, K., Grobler, L. & Sudarsanam, T. D. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database of Systematic Reviews, Issue 11. Art. No.: CD006086. http://dx.doi.org/10.1002/ 14651858.CD006086.pub3.
58. Ribeiro, R. C., Pui, C. H. & Schell, M. J. Vertebral compression fracture as a presenting feature of acute lymphoblastic leukemia in children. Cancer 61, 589-592 (1988).
59. Halton, J. et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemiaResults of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J. Bone. Miner. Res. 24, 1326-1334 (2009).
60. Antony, R. et al. Vitamin D protects acute lymphoblastic leukemia cells from dexamethasone. Leukemia Res. 36, 591-593 (2012).
61. Madden, K. et al. Vitamin D deficiency in critically ill children. Pediatrics 130, 421-428 (2012).
62. McNally, J. D. et al. The association of vitamin D status with pediatric critical illness. Pediatrics 130, 429-36 (2012).
63. Rippel, C., South, M., Butt, W. W. & Shekerdemian, L. S. Vitamin D status in critically ill children. Intensive Care Med. 38, 2055-2062, (2012).
64. Ali, F. N., Arguelles, L. M., Langman, C. B. & Price, H. E. Vitamin D deficiency in children with chronic kidney disease: Uncovering an epidemic. Pediatrics 123, 791-796 (2009).
65. Kalkwarf, H. J. et al. Vitamin D deficiency is common in children and adolescents with chronic kidney disease. Kidney Int. 81, 690-697 (2012).
66. Lavi-Moshayoff, V., Wasserman, G., Meir, T., Silver, J. & Naveh-Many, T. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: A bone parathyroid feedback loop. Am. J. Physiol. Renal Physiol. 299, F882-F889 (2010).
67. Shroff, R. et al. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: A randomized trial. Clin. J. Am. Soc. Nephrol. 7, 216-223 (2012).
68. Hari, P. et al. Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease. Pediatr. Nephrol. 25, 2483-2488 (2010).
69. Amrein, K. & Venkatesh, B. Vitamin D and the critically ill patient. Curr. Opin. Nutr. Metab. Care. 15, 188-193 (2012).
70. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am. J. Kidney Dis. 24 (Suppl. 3), 1-201 (2003).
71. Douros, K., Loukou, I., Nicolaidou, P., Tzonou, A. & Doudounakis, S. Bone mass density and associated factors in cystic fibrosis patients of young age. J. Paediatr. Child Health. 44, 681-685 (2008).
72. Grey, V. et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 122, 1014-1020 (2008).
73. Boas, S. R., Hageman, J. R., Ho, L. T. & Liveris, M. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis. J. Cyst. Fibros. 8, 270-272 (2009).
74. Tangpricha, V. et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: Evidence-based recommendations from the Cystic Fibrosis Foundation. J. Clin. Endocrinol. Metab. 97, 1082-1093 (2012).
75. Green, D. M. et al. Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients. J. Cyst. Fibros. 9, 143-149 (2010).
76. Misra, M., Pacaud, D., Petryk, A., Collett-Solberg, P. F. & Kappy, M. Vitamin D deficiency in children and its managementReview of current knowledge and recommendations. Pediatrics 122, 398-417 (2008).
77. Froicu, M. & Cantorna, M. T. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 8, 5 (2007).
78. Froicu, M. et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17, 2386-2392 (2003).
79. Fava, F. & Danese, S. Intestinal microbiota in inflammatory bowel disease: Friend of foe? World J. Gastroenterol. 17, 557-566 (2011).
80. El-Matary, W., Sikora, S. & Spady, D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig. Dis. Sci. 56, 825-829 (2011).
81. Benchimol, E. I. et al. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 45, 538-545 (2007).
82. Koczka, C. P., Abramowitz, M. & Goodman, A. J. The study of bone demineralization and its risk factors in an Afro-Caribbean subset of patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 24, 759-761 (2012).
83. Sylvester, F. A. et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm. Bowel Dis. 13, 42-50 (2007).
84. Walther, F., Fusch, C., Radke, M., Beckert, S. & Findeisen, A. Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment. J. Pediatr. Gastroenterol. Nutr. 43, 42-51 (2006).
85. Levin, A. D. et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig. Dis. Sci. 56, 830-836 (2011).
86. O'Malley, T. & Heuberger, R. Vitamin D status and supplementation in pediatric gastrointestinal disease. J. Spec. Pediatr. Nurs. 16, 140-150 (2011).
87. Pappa, H. M. et al. Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: A randomized clinical trial comparing three regimens. J. Clin. Endocrinol. Metab. 97, 2134-2142 (2012).
88. Gordon, C. M., DePeter, K. C., Feldman, H. A., Grace, E. & Emans, S. J. Prevalence of vitamin D deficiency among healthy adolescents. Arch. Pediatr. Adolesc. Med. 158, 531-537 (2004).
89. Brehm, J. M. et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol. 126, 52.e5-58.e5 (2010).
90. Chinellato, I. et al. Vitamin D serum levels and markers of asthma control in Italian children. J. Pediatr. 158, 437-441 (2011).
91. Lewis, E. et al. Relationship of 25-hydroxyvitamin D and asthma control in children. Ann. Allergy Asthma. Immunol. 108, 281-282 (2012).
92. Majak, P., Olszowiec-Chlebna, M., Smejda, K. & Stelmach, I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J. Allergy Clin. Immunol. 127, 1294-1296 (2011).
93. Guyton, A. C. Textbook of Medical Physiology, 8th edn, 889 (WB Saunders, Philadelphia, 1991).